Dawn Yates

652 total citations
11 papers, 241 citations indexed

About

Dawn Yates is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Dawn Yates has authored 11 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Dawn Yates's work include Histone Deacetylase Inhibitors Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer Treatment and Pharmacology (2 papers). Dawn Yates is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer Treatment and Pharmacology (2 papers). Dawn Yates collaborates with scholars based in United Kingdom, United States and South Africa. Dawn Yates's co-authors include Celia Dominguez, Kim L. Matthews, Omar Aziz, Roland W. Bürli, Ignacio Muñoz-Sanjuán, Marieke Lamers, Mark Wickens, Andrew J. Stott, Maria Beconi and Grant Wishart and has published in prestigious journals such as PLoS ONE, Toxicology and Drug Metabolism and Disposition.

In The Last Decade

Dawn Yates

10 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn Yates United Kingdom	8	127	47	47	43	30	11	241
Karan H. Muchhala United States	8	183 1.4×	25 0.5×	37 0.8×	135 3.1×	86 2.9×	13	325
G Bruni Italy	9	96 0.8×	12 0.3×	29 0.6×	42 1.0×	18 0.6×	47	313
Kimberly D.K. Adkison United States	6	73 0.6×	10 0.2×	162 3.4×	84 2.0×	21 0.7×	7	371
Susan P. Good United States	3	48 0.4×	24 0.5×	9 0.2×	45 1.0×	71 2.4×	3	200
Daniel R. Kirkpatrick United States	8	71 0.6×	12 0.3×	17 0.4×	17 0.4×	68 2.3×	11	306
John J. Lowery United States	8	249 2.0×	13 0.3×	12 0.3×	268 6.2×	91 3.0×	9	356
Alain Matthey Switzerland	8	55 0.4×	14 0.3×	40 0.9×	29 0.7×	35 1.2×	14	251
Maggie S. McIntyre United States	9	272 2.1×	17 0.4×	8 0.2×	73 1.7×	47 1.6×	9	464
R L Cavanagh United States	9	111 0.9×	41 0.9×	15 0.3×	70 1.6×	63 2.1×	14	335

Countries citing papers authored by Dawn Yates

Since Specialization

Citations

This map shows the geographic impact of Dawn Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Yates more than expected).

Fields of papers citing papers by Dawn Yates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Yates. The network helps show where Dawn Yates may publish in the future.

Co-authorship network of co-authors of Dawn Yates

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Yates. A scholar is included among the top collaborators of Dawn Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Yates. Dawn Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Nicol, Beate, et al.. (2024). A workflow to practically apply true dose considerations to in vitro testing for next generation risk assessment. Toxicology. 505. 153826–153826. 7 indexed citations

Luckhurst, Christopher A., Omar Aziz, Vahri Beaumont, et al.. (2018). Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(1). 83–88. 38 indexed citations

Luckhurst, Christopher A., Perla Breccia, Andrew J. Stott, et al.. (2015). Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors. ACS Medicinal Chemistry Letters. 7(1). 34–39. 42 indexed citations

Vodička, Petr, Junghyun Lim, Kimberly B. Kegel, et al.. (2014). Assessment of Chloroquine Treatment for Modulating Autophagy Flux in Brain of WT and HD Mice. Journal of Huntington s Disease. 3(2). 159–174. 29 indexed citations

Beconi, Maria, Omar Aziz, Kim L. Matthews, et al.. (2012). Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo. PLoS ONE. 7(9). e44498–e44498. 33 indexed citations

Beconi, Maria, Dawn Yates, Kathryn A. Lyons, et al.. (2012). Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048. Drug Metabolism and Disposition. 40(12). 2297–2306. 25 indexed citations

Yates, Dawn, et al.. (2001). Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR).. PubMed. 44. 75–6. 4 indexed citations

Yates, Dawn, et al.. (2001). Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in young and elderly subjects.. PubMed. 44. 79–80. 13 indexed citations

Wickens, Mark, et al.. (2001). Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment.. PubMed. 44. 81–2. 27 indexed citations

10.

Yates, Dawn, et al.. (2001). Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment.. PubMed. 44. 83–4. 22 indexed citations

11.

Yates, Dawn. (1990). A Synopsis of Rheumatic Disease. Postgraduate Medical Journal. 66(779). 793–793. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact